Skip to primary navigation Skip to main content
0 item $0.00

Inflammation and Cardiovascular Disease

Read more

Laboratory head

Close
i Profile of author

Latest Achievements

Irvine H. Page Finalist, ATVB|AHA Conference, Canada (2014)

AMREP basic science Research Award (2013)

Early Career Scientist Award, Australia Vascular Biology Society (2009)

Read full biography
Dr Tin Kyaw Laboratory Head
We are dedicated to understanding how both adaptive and innate immune systems contribute to inflammation in cardiovascular diseases, to develop early detection and effective intervention strategies.

Staff

Research staff

Dr Kurt Brassington Mr Peter Kanellakis

 

About the Inflammation and Cardiovascular Disease laboratory

The Inflammation and Cardiovascular Diseases laboratory uses a multi-disciplinary approach to understand how the immune system and inflammation modulate the pathogenesis of cardiovascular diseases.

Inflammation is a protective response triggered by damage to living cells. This response localises and eliminates the injurious agents, while also removing damaged tissue components so that the body can heal and maintain homeostasis. In cardiovascular diseases, the injury may be caused by internal factors (e.g. myocardial infarction (MI) rather than external factors such as bacteria or viruses). The immune system is largely responsible for initiating inflammation and untreated acute (subclinical) inflammation leads to chronic inflammation that eventually causes cell damage (e.g arteries). Our areas of focus are vascular inflammation (atherosclerosis) and cardiac inflammation (cardiomyopathy). 

We will decipher how both adaptive and innate systems contribute to inflammation in cardiovascular diseases in animal models. We aim to translate these findings into practice in both diagnostics for early detection and therapeutics for effective intervention to prevent premature plaque ruptures.

Current research interests

  1. Better understanding and preventing recurrent myocardial infarctions.
  2. CD4+ regulatory T cells and preventing/reversing the development of vulnerable atherosclerotic plaques associated with unstable angina and MI/stroke.
  3. Understanding how gamma-delta T cells contribute to vulnerable plaque development.
  4. Myocardial inflammation associated with myocardial infarction.
  5. Diffuse interstitial cardiac fibrosis.

Support us

With the rising number of Australians affected by diabetes, heart disease and stroke, the need for research is more critical than ever.

Find out more